Journal of Commercial Biotechnology — October 2009 issue now available

The October 2009 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 15, Issue 4

Editorial

Intellectual property and biotechnology innovation: To protect or not protect?PDF
Yali Friedman

Commentary

The correlation between medical tourism and biotechnologyPDF
David G Vequist IV, Erika Valdez
The VC manifesto: Special pleading for a damaged cause: Commentary on Simon Witney interviewPDF
William Bains

Articles

Innovate America: The Technology Innovation Program at NISTPDF
Andrew S Klein, Mrunal S Chapekar
Valuation of complex license contractsPDF
Ralph Villiger, Boris Bogdan
How can pharmaceutical and biotechnology companies maintain a high profitability?PDF
Klaus J Nickisch, Joachim M Greuel, Kerstin M Bode-Greuel
Multiyear patterns regarding the relative availability of venture capital for the US biotechnology industryPDF
J Leslie Glick
Building biotechnology teams: Personality does matterPDF
Anne S York, Kim A McCarthy, Todd C Darnold
Beacon Sciences: Commercialisation from biothreat detection to beauty enhancementPDF
Rob Hanes, Damon Borich

Legal and Regulatory Updates

Legal and Regulatory UpdatePDF
Gerry Kamstra, John Wilkinson

Book Reviews

Book Review: Genomics & society: Legal, ethical and social dimensionsPDF
Dominic Clark
Book Review: Commercialization of innovative technologies: Bringing good ideas to the marketplacePDF
Arlen D Meyers
Book Review: Biotech funding trends: Insights from entrepreneurs and investorsPDF
J Leslie Glick


Comments are closed.

Biotechblog